| Dr Ryan H Larsen, MD | |
|
258 S Main St Ste 210, Logan, UT 84321-5768 | |
| (435) 383-6120 | |
| (435) 557-8003 |
| Full Name | Dr Ryan H Larsen |
|---|---|
| Gender | Male |
| Speciality | General Practice |
| Location | 258 S Main St Ste 210, Logan, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235224932 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208D00000X | General Practice | 175141-1205 (Utah) | Primary |
| Entity Name | Atlas Medical Utah Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568928133 PECOS PAC ID: 4981937034 Enrollment ID: O20190605001965 |
News Archive
A small number of patients infected by HIV spontaneously control viral replication without antiretroviral therapy, and do not develop the disease. The ability of these rare patients, known as "HIV controllers", to suppress HIV replication appears to be down to a highly effective immune response.
Since the earliest study about nursing faculty and students attitudes and beliefs about caring for people living with HIV/AIDS (PLHIV) in the early 1990's, there have only been 17 additional studies. Knowledge in this area of study is still lacking to fill some gaps in understanding attitudes towards people living with the disease.
Aurora Imaging Technology, Inc. today announced the installation of the Aurora® Dedicated Breast MRI System in China at the world-renowned Ruijin Hospital located in Shanghai, the teaching hospital for China's top-tiered Jiao Tong University Medical School. The installation marks the first Aurora System in China.
Cytori Therapeutics announced today its fall 2010 conference schedule.
Insilico Medicine a leader in artificial intelligence for drug discovery, biomarker development and aging research, announced a research collaboration agreement with A2A Pharmaceuticals, Inc. A2A is a biotechnology company headquartered in New York and focused on development of novel drugs for unmet needs in oncology, drug resistant bacterial infections, and other life threatening diseases.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ryan H Larsen, MD 258 S Main St Ste 210, Logan, UT 84321-5768 Ph: (435) 383-6120 | Dr Ryan H Larsen, MD 258 S Main St Ste 210, Logan, UT 84321-5768 Ph: (435) 383-6120 |
News Archive
A small number of patients infected by HIV spontaneously control viral replication without antiretroviral therapy, and do not develop the disease. The ability of these rare patients, known as "HIV controllers", to suppress HIV replication appears to be down to a highly effective immune response.
Since the earliest study about nursing faculty and students attitudes and beliefs about caring for people living with HIV/AIDS (PLHIV) in the early 1990's, there have only been 17 additional studies. Knowledge in this area of study is still lacking to fill some gaps in understanding attitudes towards people living with the disease.
Aurora Imaging Technology, Inc. today announced the installation of the Aurora® Dedicated Breast MRI System in China at the world-renowned Ruijin Hospital located in Shanghai, the teaching hospital for China's top-tiered Jiao Tong University Medical School. The installation marks the first Aurora System in China.
Cytori Therapeutics announced today its fall 2010 conference schedule.
Insilico Medicine a leader in artificial intelligence for drug discovery, biomarker development and aging research, announced a research collaboration agreement with A2A Pharmaceuticals, Inc. A2A is a biotechnology company headquartered in New York and focused on development of novel drugs for unmet needs in oncology, drug resistant bacterial infections, and other life threatening diseases.
› Verified 1 days ago